Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
University of California Los Angeles
Los Angeles, California
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 861. We're showing you the first 500 records. If you need every record from this institution, you can download all of our data at the ProPublica Data Store.
Name | Type | Company | Disclosed Value | Year Filed |
---|---|---|---|---|
Pouratian Nader | Financial Disclosure | Second Sight Medical Products, Inc. | 2018 | |
Maxime Cannesson | Financial Disclosure | Masimo Corporation | 2018 | |
Maxime Cannesson | Financial Disclosure | Masimo Corporation | 2018 | |
Daniel Z. Uslan | Financial Disclosure | Finch Therapeutics | 2018 | |
Jason S. Bradfield | Financial Disclosure | Abbott | 2018 | |
Perry Shieh | Financial Disclosure | Sarepta Therapeutics | 2018 | |
Saggar | Financial Disclosure | Actelion Pharmaceuticals | 2018 | |
Saggar | Financial Disclosure | Chiltern International Spz | 2018 | |
Xianghong Jasmine Zhou | Financial Disclosure | Early Diagnostics | 2018 | |
Karoly Holczer | Financial Disclosure | SomaLogic, Inc. | 2018 | |
James Rosenzweig | Financial Disclosure | Radiabeam Technology, LLC | 2018 | |
Gary John Schiller | Financial Disclosure | Incyte Corporation | 2018 | |
Gary John Schiller | Financial Disclosure | Incyte Corporation | 2018 | |
Jonathan Goldman | Financial Disclosure | AstraZeneca | 2018 | |
Jonathan Goldman | Financial Disclosure | Genentech | 2018 | |
Sara A. Hurvitz | Financial Disclosure | TRIO-US | 2018 | |
Zev Wainberg | Financial Disclosure | Array BioPharma Inc. | 2018 | |
Sara Asterlind Hurvitz | Financial Disclosure | TRIO-US | 2018 | |
Antoni Ribas | Financial Disclosure | Novartis Pharmaceuticals | 2018 | |
Antoni Ribas | Financial Disclosure | Novartis Pharmaceuticals | 2018 | |
Dennis Slamon | Financial Disclosure | TRIO-Global | 2017 | |
Asad Abidi | Financial Disclosure | Analog Devices | 2018 | |
Bernard Churchill | Financial Disclosure | MicrobeDx, Inc. | 2018 | |
Matteo Pellegrini | Financial Disclosure | Prosper DNA Inc. | 2018 | |
Jamil A. Aboulhosn | Financial Disclosure | Edwards Lifesciences LLC | 2018 | |
Daniel Z. Usian | Financial Disclosure | Finch Therapeutics | 2018 | |
Leonard H. Rome | Financial Disclosure | Vault Nano Inc. | 2018 | |
Nader Pouratian | Financial Disclosure | Second Sight medical Products, Inc | 2018 | |
Michael E. Jung | Financial Disclosure | Kynan Pharmaceuticals | 2018 | |
Sarah Helen Tolbert | Financial Disclosure | Battery Streak | 2018 | |
Tsu-Chin Tsao | Financial Disclosure | Industrial Technology Research Institute | 2018 | |
Schiller J. Gary | Financial Disclosure | Bristol-Myers Squibb | 2018 | |
Antoni Ribas | Financial Disclosure | Merck | 2018 | |
Bartosz Chmielowski | Financial Disclosure | Compugen Ltd. | 2018 | |
Antoni Ribas | Financial Disclosure | Merck | 2018 | |
Antoni Ribas | Financial Disclosure | Merck | 2018 | |
David Sarraf | Financial Disclosure | Genentech | 2018 | |
Perry Shieh | Financial Disclosure | Biogen | 2018 | |
Gary J. Schiller | Financial Disclosure | Pfizer | 2018 | |
Antoni Ribas | Financial Disclosure | Amgen | 2018 | |
Stacy Calhoun | Financial Disclosure | Center for Council | 2018 | |
Suphamai Bunnapradist | Financial Disclosure | Bristol-Myers Squib Co. | 2018 | |
Keith H. Nuechterlein | Financial Disclosure | Janssen Scientific Affairs, LLC | 2018 | |
Stephen Samuel Weigt | Financial Disclosure | Boehringer Ingelheim | 2018 | |
Michael Ip | Financial Disclosure | Genentech | 2018 | |
Richard B. Kaner | Financial Disclosure | Hydrophilix Inc. | 2018 | |
Joel Randolph Hecht | Financial Disclosure | Merck | 2018 | |
Jonathan W. Goldman | Financial Disclosure | AstraZeneca | 2018 | |
Scott G. Kitchen | Financial Disclosure | Gilead Sciences Inc. | 2018 | |
David Walker | Financial Disclosure | AMWAY | 2018 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.